Nivolumab plus ipilimumab immunotherapy-related irAEs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2035卷 / 1期
关键词：
D O I：
10.1007/s40278-024-70759-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 9
相关论文
共 50 条
  • [1] Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
    Patel, Sapna P.
    Sheth, Rahul A.
    Davis, Christina
    Medina, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08)
  • [2] The efficacy of combination immunotherapy with ipilimumab plus nivolumab in metastatic myxofibrosarcoma
    Kalofonou, Foteini
    Napolitano, Andrea
    Benson, Charlotte
    Miah, Aisha
    Zaidi, Shane
    Lindsay, Daniel
    Thway, Khin
    Jones, Robin L.
    RARE TUMORS, 2024, 16
  • [3] Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis
    Wang, QuanQiu
    Xu, Rong
    JAMIA OPEN, 2019, 2 (01) : 173 - 178
  • [4] Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
    Menzer, Christian
    Beedgen, Bernd
    Rom, Joachim
    Duffert, Christin M.
    Volckmar, Anna-Lena
    Sedlaczek, Oliver
    Richtig, Erika
    Enk, Alexander
    Jaeger, Dirk
    Hassel, Jessica C.
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 239 - 242
  • [5] Nivolumab Plus Ipilimumab For Prostate Cancer
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (01) : 16 - 16
  • [6] Immunotherapy also effective in malignant Melanoma with a high Tumor Burden (Ipilimumab plus Nivolumab)
    Jaeger, K.
    Khoschbin, T.
    Dabrowski, E.
    Dippel, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 54 - 54
  • [7] Nivolumab plus Ipilimumab in Advanced Melanoma
    Wolchok, Jedd D.
    Kluger, Harriet
    Callahan, Margaret K.
    Postow, Michael A.
    Rizvi, Naiyer A.
    Lesokhin, Alexander M.
    Segal, Neil H.
    Ariyan, Charlotte E.
    Gordon, Ruth-Ann
    Reed, Kathleen
    Burke, Matthew M.
    Caldwell, Anne
    Kronenberg, Stephanie A.
    Agunwamba, Blessing U.
    Zhang, Xiaoling
    Lowy, Israel
    Inzunza, Hector David
    Feely, William
    Horak, Christine E.
    Hong, Quan
    Korman, Alan J.
    Wigginton, Jon M.
    Gupta, Ashok
    Sznol, Mario
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 122 - 133
  • [8] Nivolumab plus ipilimumab for advanced MPM
    Venkatesan, Priya
    LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : E76 - E76
  • [9] Adverse events with nivolumab plus ipilimumab
    Reactions Weekly, 2017, 1671 (1) : 8 - 8
  • [10] Ipilimumab plus nivolumab for advanced melanoma
    Hassel, Jessica C.
    LANCET ONCOLOGY, 2016, 17 (11): : 1471 - 1472
12345